top of page
Epilepsy pipeline conference
Come Join Us!
Interested in epilepsy treatment, therapeutic innovation, and product development? Join us at the virtual Epilepsy Foundation Pipeline Conference, August 27-28, 2020.
The Epilepsy Foundations Pipeline Conference brings together decision makers with a stake in the field of epilepsy treatment, therapeutic innovation, and product development.
Join NeuCyte's Presentation
Based on its proprietary technology for generating human iPSC-derived induced neuronal cells, NeuCyte has developed an in vitro human neural platform for complex electrophysiological and morphological readouts suited for target identification and validation, efficacy testing, and neurotoxicity assessment. Using patient-derived and genetically engineered defined neural cell types, NeuCyte builds unique cell-based assays for modeling neurological and neurodegenerative disorders.
This presentation will be included in Session V, Day 2.
Date: August 28, 2020
Session Title: Screening
Session Time: 9:05 am
Thomas Portmann PhD,
Head of Research, NeuCyte
NeuCyte is committed to developing epilepsy treatment. For more information about our drug discovery programs and our first-in-class lead epilepsy compound NC-201, please visit: neucyte.com/drug-discovery
bottom of page